Latest Kaiser Health News Stories
KHN senior correspondent Angela Hart discusses how California’s big Medicaid experiment to bring social services to the sickest and costliest patients doesn’t help most patients.
The government soon will stop paying for the covid drug that has proved to be the most effective at keeping patients alive and out of the hospital.
KHN senior correspondent Angela Hart discussed the most pressing health care issues in California with the nonpartisan group Democracy Winters in mid-November, touching on a variety of issues, from the state’s effort to transform its Medicaid program to its plan to produce generic insulin.
Health insurers and health care systems across the country are violating disability rights laws by sending medical bills that blind and visually impaired people cannot read, a KHN investigation has found. By hindering the ability of blind Americans to know what they owe, some bills get sent to debt collections.
The lame-duck Congress has returned to Washington with a long health care to-do list and only a little time. Meanwhile, some of the states that have not yet expanded Medicaid eligibility under the Affordable Care Act are rethinking those decisions. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews KHN’s Fred Clasen-Kelly, who reported and wrote the latest KHN-NPR “Bill of the Month” feature, about a mysterious mishap during minor surgery.
Federally funded clinics and their doctors are protected against lawsuits by federal law, with taxpayers footing the bill. The health centers say that allows them to better serve their low-income patients, but lawyers say the system handcuffs consumers with a cumbersome legal process and makes it harder for the public to see problems.
Privacy concerns and coverage limits have long made insurance an unreliable option for abortion access. For decades, abortion funds have been stepping in to help people pay for what they see as essential health care.
New U.S. Census Bureau data shows a large segment of Californians are working from home for part or all of the week. Researchers say the shift will ripple through the broader economy in ways big and small.
Democrats retained control of the U.S. Senate in the midterm elections, while Republicans won a majority in the House, giving them the ability to block items on President Joe Biden’s agenda. Meanwhile, the lame-duck, Democratic-led Congress won’t have the votes to pass abortion rights legislation, although they may try to undo some long-standing anti-abortion policies in federal spending bills. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Victoria Knight of Axios, and Alice Miranda Ollstein of Politico, join KHN’s Julie Rovner to discuss these topics and more.
Hospitals strike deals with financing companies, generating profits for lenders, and more debt for patients.
A new documentary, “InHospitable,” explores how disputes between big hospitals can leave patients with few options for care and imperil their health.
Private equity firms have shelled out almost $1 trillion to acquire nearly 8,000 health care businesses, in deals almost always hidden from federal regulators. The result: higher prices, lawsuits, and complaints about care.
California is collecting hundreds of millions of dollars a year in tax penalties from uninsured residents. The state was supposed to use the money to help lower costs for Californians who couldn’t afford insurance but hasn’t distributed any of the revenue it has collected — citing uncertain economic times.
For many Americans, it’s open enrollment season for 2023 health insurance. One listener asked: If you don’t have a job and are too old to be on your parents’ plan, does it make sense to rely on charity care? This episode breaks it all down.
Election night went better than expected for Democrats. Although they could still lose control of one or both houses of Congress, the predicted “red wave” for Republicans failed to materialize. Meanwhile, voters in both red and blue states approved ballot measures to protect abortion rights. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews Carolee Lee, the former jewelry magnate, about her efforts to boost gender equity in medical research.
In Montana and across the nation, homeless shelters are reporting that people older than 60 are a growing proportion of their populations.
Women who need abortion care come to Michigan from surrounding states that already have banned the procedure. A clinic in suburban Detroit allowed a reporter to interview patients, doctors, and nurses to understand what is at stake as voters decide whether to guarantee abortion access in the Michigan Constitution.
Science Friday and KHN ran the numbers on birth control failure. Depending on the contraception method, typical-use error rates can add up to hundreds of thousands of unplanned pregnancies each year.
Centene, the largest Medicaid managed-care company in the U.S., has thrown more than $26.9 million at political campaigns across the country since 2015, especially focused on states where it is wooing Medicaid contracts and settling accusations that it overbilled taxpayers. Among its tactics: Centene is skirting contribution limits by giving to candidates through its many subsidiaries.
The Affordable Care Act’s 10th annual open-enrollment period began Nov. 1 and runs through Jan. 15, 2023, in most states. But for the first time, the health law seems to be enrolling Americans with far less controversy than in previous years. Meanwhile, as Election Day approaches, Democrats are focusing on GOP efforts to cut Social Security and Medicare. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Tami Luhby of CNN, and Julie Appleby of KHN join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews KHN’s Arthur Allen, who wrote the latest KNH-NPR Bill of the Month, about an old but still very expensive cancer drug.